1886.00GBp-0.30%Mkt Cap: 75.18B GBpP/E: 13.19Last update: 2026-05-13
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)13.19
P/E (Forward)9.52
PEG0.50
P/B4.19
P/S2.28
EV/EBITDA7.88
EV/Revenue2.75
EPS (TTM)1.42
EPS (Forward)1.96
Cash Flow & Leverage
FCF Yield4.02%
FCF Margin9.21%
Operating CF7.74B GBp
CapEx (TTM)2.98B GBp
Net Debt/EBITDA1.37
Net Debt15.67B GBp
Technical
SMA 502022.05 (-6.7%)
SMA 2001825.28 (+3.3%)
Beta0.30
S&P 52W Chg24.23%
Avg Vol (30d)7.73M
Avg Vol (10d)8.86M
Technical Indicators
RSI (14)35.5
MACD-59.1630
MACD Signal-45.0855
MACD Hist.-14.0775
BB Upper2230.73 GBp
BB Middle2000.11 GBp
BB Lower1769.50 GBp
BB Width23.06%
ATR (14)48.95 GBp
Vol Ratio (20d)0.56x
52W Range
1288.6060% of range2282.00
52W High2282.00 GBp
52W Low1288.60 GBp
Profitability
Gross Margin72.40%
EBITDA Margin34.88%
Profit Margin17.50%
Oper. Margin36.28%
ROE34.90%
ROA9.35%
Revenue Growth1.50%
Earnings Growth8.40%
Balance Sheet
Debt/Equity1.08
Current Ratio0.79
Quick Ratio0.51
Book Value/Sh4.441 GBp
Cash/Share0.8560 GBp
Dividends
Fwd Div Rate0.6800 GBp
Trail. Div Rate0.6700 GBp
Div. Yield3.65%
5Y Avg Yield4.41%
Payout Ratio46.45%
Ex-Div DateMay 14, 2026
Pay Date—
Splits
Last Split4:5
Split DateJul 19, 2022
Ownership
Shares Out.4.02B
Float3.89B
Insiders1.74%
Institutions46.39%
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)2032.00 GBp
Target Range1455.00 GBp – 2750.00 GBp
# Analysts20
Company
Market Cap75.18B GBp
Enterprise Value90.11B GBp
Revenue (TTM)32.78B GBp
Gross Profit23.65B GBp
Net Income (TTM)5.72B GBp
Revenue/Share8.124 GBp
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees66.8K
Last Price1886.00 GBp
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB00BN7SWP63